TSC1 and neoplasm: We further examined the NK cell-mediated in vivo rejection of RMA-S cells, an NK-sensitive tumour cell line, and observed that the severe defect in the Tsc1−/− mice was nearly comparable to that in immunocompromised mice (Fig. 3b).